The Found Script
Go beyond finding medications. Expert guides, shortage updates, and tips for navigating the healthcare system.
Browse all articles A–Z →
Amlodipine/Hydrochlorothiazide/Valsartan Shortage: What Providers and Prescribers Need to Know in 2026
A provider briefing on Amlodipine/Hydrochlorothiazide/Valsartan (Exforge HCT) availability, prescribing considerations, and patient access strategies in 2026.
Apremilast Shortage: What Providers and Prescribers Need to Know in 2026
A provider briefing on Apremilast (Otezla) access challenges in 2026. Covers availability, prior authorization, cost barriers, alternatives, and tools to help patients.
Mercaptopurine Shortage: What Providers and Prescribers Need to Know in 2026
A provider-focused briefing on the Mercaptopurine shortage in 2026: supply timeline, prescribing implications, alternatives, and tools to help patients.
Dymista Shortage: What Providers and Prescribers Need to Know in 2026
A provider briefing on Dymista availability in 2026. Current supply status, prescribing implications, cost data, and tools to help your patients.
40,000+ have already found their meds with Medfinder.
Stop calling pharmacies. Start your search today.
Opzelura Shortage: What Providers and Prescribers Need to Know in 2026
A provider briefing on Opzelura availability in 2026. Learn about distribution challenges, prescribing implications, cost barriers, and tools to help patients.
Rifaximin Shortage: What Providers and Prescribers Need to Know in 2026
A provider briefing on Rifaximin (Xifaxan) availability in 2026: supply timeline, prescribing implications, cost barriers, and tools to help patients.
Camrese 91 Day Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing on the Camrese 91 Day shortage for providers. Includes prescribing guidance, alternatives, availability tools, and patient communication tips.
Quillivant XR Shortage: What Providers and Prescribers Need to Know in 2026
A provider-focused briefing on the Quillivant XR shortage in 2026. Covers timeline, prescribing implications, availability data, cost considerations, and clinical tools.
Lisdexamfetamine Shortage: What Providers and Prescribers Need to Know in 2026
A provider briefing on the 2026 Lisdexamfetamine shortage: DEA quota updates, prescribing implications, alternative options, and tools for your practice.
Augmentin Shortage: What Providers and Prescribers Need to Know in 2026
A provider briefing on the 2026 Augmentin shortage: timeline, prescribing implications, availability by formulation, cost impacts, and clinical alternatives.
Omnitrope Shortage: What Providers and Prescribers Need to Know in 2026
A provider-focused 2026 briefing on Omnitrope availability, the somatropin market, prior authorization challenges, and clinical guidance for managing patient access.
How to Help Your Patients Save Money on Mydayis XR: A Provider's Guide to Savings Programs
A practical guide for prescribers on reducing Mydayis XR costs for patients: coupon cards, insurance optimization, prior authorization tips, and when to consider alternatives.